Research Article

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes

Table 5

Continuous glucose-monitoring findings of subjects with and without macrovascular disease.

VariableNo macrovascular disease ()Macrovascular disease () value

Highest value (mmol/L)13.4 (11.3–15.85)13.0 (11.3–15)0.35
Lowest value (mmol/L)4.4 (3.2–5.25)3.7 (2.8–5)0.09
Mean blood glucose (mmol/L)7.6 (6.85–9.0)7.3 (6.6–8.4)0.3
Standard deviation (mmol/L)3.0 (1.3–2.3)1.8 (1.5–2.4)0.9
Number of high excursions8 (6–10)8 (5–10)0.49
Number of low excursions0 (0–2)1 (0–2)0.10
AUC above 7.8 mmol/L0.64 (0.24–1.76)0.57 (0.21–1.35)0.39
AUC below 3.9 mmol/L0 (0–0.01)0 (0–0.03)0.05
Duration during 72 hr period with BG above 7.8 mmol/L (%)37 (18.5–66.5)35 (20–58)0.39
Duration during 72 hr period with BG within 3.9–7.8 mmol/L (%)58 (31.5–79)60 (41–77)0.63
Duration during 72 hr period with BG below 3.9 mmol/L (%)0 (0-1)1 (0–5)0.02

Values are expressed as number (%) of patients or median (IQR). AUC: area under curve.